Joan Connolly
Chief Technology OfficerMs. Joan Connolly is Chief Technology Officer of enGene Therapeutics Inc. (formerly known as enGene Holdings Inc.) from October 21, 2024. She served as Chief Technology Officer at Albireo Pharma, Inc. since April 2021. She served as Associate Vice President of Strategy & Operations at ImClone Systems Incorporated. She has experience in manufacturing management, regulatory filings (CMC) and product commercialization, as well as supply chain, logistics and sourcing and procurement. She was the Senior Vice President, Technical Operations at Stemline Therapeutics where she was responsible for taking their lead product from the IND stage through to commercialization. She served senior roles at ImClone Systems and Bristol-Myers Squibb. Ms. Connolly holds a B.Sc. in Engineering Chemistry from Queen’s University.
Positions
- Company NameenGene Therapeutics Inc.Stock CodeENGNPositionChief Technology OfficerRelated SecuritiesColleagues
- RHRonald H. W. CooperPresident, CEO & Director
- MTMichael Thomas HeffernanIndependent Non-Executive Chairman
- KRKathleen RichtonSenior VP of Finance, Principal Accounting & Financial Officer and Controller
- JGJason G. DuncanChief Legal & Administrative Officer
- LSLauren Stival HopferExecutive Director of Investor Relations
- PDPaul D. RobbinsChairman of Scientific Advisory Board
- LSLota S. ZothIndependent Non-Executive Director
- WSWouter Sebastian Johannes JoustraIndependent Non-Executive Director
